Brief: X4 Pharmaceuticals Q4 EPS USD -0.1
21/03/2024 10:01
Mar 21 (Reuters) - X4 Pharmaceuticals Q4 operating expenses USD 25.199 million. * Q4 net income USD -19.13 million * Q4 income from operations USD -25.199 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule